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SUMMARy – diffuse toxic goiter, as the most common cause of hyperthyroidism, is usually 
initially treated with thyrostatic drugs such as methimazole, followed by radioiodine therapy or sur-
gery which may be indicated as definitive treatment. Radioactive iodine therapy has a known associa-
tion with various histopathologic features including cytologic atypia, but herein we present a rare ex-
ample of morphological thyrocyte changes induced by long-term pharmacological treatment with 
methimazole that mimicked thyroid malignancy in a pathohistological sample.
Key words: hyperthyroidsm, thyrostatic drugs, thyroid neoplasms
Corresponding author: Ana Barić, Md, phd
E-mail: ana.baaric@gmail.com
Introduction
diffuse toxic goiter is the most common cause of 
hyperthyroidism, with an overall prevalence up to 
1.3% and clinical symptoms of hypermetabolism and 
some extrathyroidal manifestations like ophthalmopa-
thy and dermopathy. it is an autoimmune disease 
caused by interplay of genetic and environmental fac-
tors, with higher incidence in women than in men [1]. 
Therapy includes thyrostatic drugs or radioiodine 
therapy and surgery if spontaneous remission is not 
achieved. in the past, the association of radioactive io-
dine therapy with various histopathologic features in-
cluding cytologic atypia has been described [2-6]. in 
this paper, we present a rare example of morphological 
thyrocyte changes induced with long-term methima-
zole therapy that mimicked thyroid malignancy in a 
pathohistological sample.
Case report
A 67-year-old female patient presented with trem-
or, palpitations, sweating, and weight loss that lasted 
for 2 months; laboratory findings indicated high level 
of total thyroxine and triiodothyronine with sup-
pressed tSh levels. The patient also presented with 
atrial fibrillation.
Thyroid ultrasound revealed diffuse thyroid goiter 
that indicated diffuse toxic goiter. Thyrostatic therapy 
was introduced as a 60 mg dose of of methimazole 
daily for the first 7 days with gradual decrease in 
10-day intervals. After 5 weeks, the patient showed 
good therapy response with normalization of thyroid 
hormone levels and clinical remission, so maintenance 
therapy was continued with 10 mg of methimazole 
daily. two years later, the patient developed mild to 
severe ophthalmopathy. despite suggestions and indi-
cations, the patient rejected surgery so methimazole 
therapy was continued with some relapses and dose 
adjustment. four years later, the patient agreed to sur-
gical treatment and total thyroidectomy was per-
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formed. At the time of the surgery the patient was re-
ceiving a lower dose of 10-15 mg methimazole daily. 
in the early postoperative period, the patient presented 
with a complication that consisted of hemorrhage with 
urgent tracheotomy and 24 h mechanic ventilation 
and good recovery during next few days.
Histologic features
gross features: The left lobe measured 5×4×2 cm in 
diameter while the right lobe measured 5×4×3 cm. his-
tologic features: surgically resected thyroid gland 
showed incomplete regression combined with hyper-
plastic changes. Thyroid tissue showed pronounced 
nodularity accompanied with perinodular fibrosis. The 
amount of lighter colloid varied in different areas, and 
epithelial hyperplasia with focal papillary hyperplasia 
was observed. psammoma bodies were also present. fol-
licular cells focally showed marked cellular polymor-
phism with nuclear atypia and hyperchromasia (figure 
1a). immunostains revealed cells positive for ttf-1 
(figure 1b), negative for CK 19 (figure 1c), and with 
proliferative activity below 5% measured by expression 
of the Ki-67 proliferative marker (figure 1d).
Discussion
our case report represents rare example of me-
thimazole-induced morphological change in thyroid 
Figure 1a. High-power view showing foci of cytologic 
atypia (hematoxylin and eosin ×20)
Figure 1b. Diffuse immunoreactivity for TTF-1 (×20).
Figure 1c. Lack of Immunoreactivity for CK 19 (×20).
Figure 1d. Low proliferative Ki-67 index (×20).
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cells that may mimic thyroid malignancy on pathohis-
tological examination.
on a histologic basis, differential diagnosis com-
prised thyroid neoplasia, particularly papillary carci-
noma. The morphological differentiation between 
these two entities, accompanied with clinical history 
and laboratory tests, posed a great challenge and re-
quireddetailed analysis to exclude the malignancy 
[7,8].
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Sažetak
UČinAK tERApiJE MEtiMAzoloM nA pAtohiStoloŠKi izglEd tKiVA ŠtitnJAČE  
KoJi MoŽE oponAŠAti MAlignE pRoMJEnE
A. Punda, A. Barić, Z. Čolović, M. Kontić, H. Punda i V. Pešutić Pisac
difuzna toksična struma, kao najučestaliji uzrok hipertireoze, se uglavnom liječi tireostaticima kao što je metimazol a 
nakon početne farmakološke terapije, ukoliko ne dođe do spontane remisije bolesti, liječenje se nastavlja primjenom radioak-
tivnog joda (i-131) ili kirurškim zahvatom.
primjena radioaktivnog joda dovodi do brojnih histopatoloških izmjena u parenhimu štitnjače, uključujući i staničnu 
atipiju, no u našem radu prikazujemo rijedak slučaj utjecaja dugotrajne farmakološke terapije metimazolom na izmjenu 
morfologije tireocita koja može oponašati izgled malignih stanica na histološkom uzorku tkiva štitnjače.
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